CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleMarket cap is $1.73B, above the global median of $1.18B
- FinancialsAltman Z-Score 7.22: safe zone
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.06%
Annual Rate
CNY 0.12Paid unknown
Payout Ratio
57.1%Sustainable
Last Ex-Dividend
Jun 18, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
11.56BCNY1.73B · vs all stocks (USD)
Trailing P/E
59.29xRevenue (TTM)
1.64BCNY245.30M · vs all stocks (USD)
Profit Margin
12.01%Beta
0.0830xvs all stocks
52-Week Change
-41.82%vs all stocks
Forward Annual Dividend Yield
1.06%vs all stocks
Market Capitalization
11.56BCNY1.73B · vs all stocks (USD)
Enterprise Value
8.25BCNY1.23B · vs all stocks (USD)
Trailing P/E
59.29xPrice to Sales (TTM)
7.03xPrice to Book (MRQ)
3.58xEnterprise to Revenue
5.02xEnterprise to EBITDA
26.36xGross Margin
79.51%Profit Margin
12.01%Operating Margin
5.83%Return on Assets (TTM)
2.64%Return on Equity (TTM)
6.12%Revenue (TTM)
1.64BCNY245.30M · vs all stocks (USD)
Revenue per Share (TTM)
1.75CNYUpdated Sep 21, 2026Quarterly Revenue Growth
-22.00%Gross Profit (TTM)
1.32BCNY196.78M · vs all stocks (USD)
EBITDA (TTM)
276.13MCNY41.23M · vs all stocks (USD)
Net Income (TTM)
197.25MCNY29.45M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-65.60%Operating Cash Flow (TTM)
377.20MCNY56.33M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
2.90MCNY432.73K · vs all stocks (USD)
Forward Annual Dividend Rate
0.1200CNYUpdated Sep 21, 2026Forward Annual Dividend Yield
1.06%vs all stocks
Trailing Annual Dividend Rate
0.1200CNYUpdated Sep 21, 2026Trailing Annual Dividend Yield
1.06%vs all stocks
Payout Ratio
57.14%Minority Interest (Equity)
58.71MCNYFY2025 · Dec 31, 2025Revenue
1.78BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
351.87MCNYFY2025 · Dec 31, 2025Gross Profit
1.43BCNYFY2025 · Dec 31, 2025Operating Income
236.77MCNY35.36M · vs all stocks (USD)
Pre-tax Income
253.09MCNYFY2025 · Dec 31, 2025Income Tax Expense
39.38MCNYFY2025 · Dec 31, 2025Net Income
213.72MCNYFY2025 · Dec 31, 2025EBIT
253.99MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
369.78MCNYFY2025 · Dec 31, 2025Research & Development
158.61MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
962.82MCNYFY2025 · Dec 31, 2025Other Operating Expenses
27.62MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
14.03MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
895.88KCNYFY2025 · Dec 31, 2025EPS (Basic)
0.2500CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.2500CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
946.40MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
946.40MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
213.72MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
22.89MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
290.83MCNYFY2025 · Dec 31, 2025Free Cash Flow
147.42MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
1.41BCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
213.72MCNYFY2025 · Dec 31, 2025Other Non-cash Items
6.31MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
967.81KCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
69.84MCNYFY2025 · Dec 31, 2025Capital Expenditures
-143.41MCNYFY2025 · Dec 31, 2025Net Acquisitions
519.95KCNYFY2025 · Dec 31, 2025Purchase of Investments
-4.78BCNYFY2025 · Dec 31, 2025Sale of Investments
4.49BCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-440.67MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
47.00MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-82.00MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-111.47MCNYFY2025 · Dec 31, 2025Other Financing Charges
26.05MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-120.43MCNYFY2025 · Dec 31, 2025Shares Outstanding
928.16MSharesUpdated Sep 21, 2026Float Shares
264.66MSharesUpdated Sep 21, 2026% Held by Insiders
71.53%vs all stocks
% Held by Institutions
7.58%vs all stocks
Total Cash (MRQ)
2.34BCNY348.74M · vs all stocks (USD)
Total Cash per Share (MRQ)
2.52CNYUpdated Sep 21, 2026Total Debt (MRQ)
6.37MCNY951.60K · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0019xCurrent Ratio (MRQ)
2.75xBook Value per Share (MRQ)
3.47CNYUpdated Sep 21, 2026Total Assets
4.52BCNY674.54M · vs all stocks (USD)
Total Current Assets
2.99BCNYFY2025 · Dec 31, 2025Total Liabilities
1.24BCNYFY2025 · Dec 31, 2025Total Non-current Assets
1.53BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
76.14MCNYFY2025 · Dec 31, 2025Total Current Liabilities
1.17BCNYFY2025 · Dec 31, 2025Cash
1.42BCNYFY2025 · Dec 31, 2025Cash Equivalents
2.08MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
1.42BCNYFY2025 · Dec 31, 2025Other Short-term Investments
1.06BCNYFY2025 · Dec 31, 2025Accounts Receivable
205.48MCNYFY2025 · Dec 31, 2025Inventory
124.55MCNYFY2025 · Dec 31, 2025Accounts Payable
121.07MCNYFY2025 · Dec 31, 2025Short-term Debt
29.79MCNYFY2025 · Dec 31, 2025Other Current Liabilities
4.58MCNYFY2025 · Dec 31, 2025Long-term Debt
4.04MCNYFY2025 · Dec 31, 2025Common Stock (Book)
928.16MCNYFY2025 · Dec 31, 2025Retained Earnings
1.87BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
3.27BCNY488.92M · vs all stocks (USD)
52-Week Low
11.02CNYUpdated Sep 21, 202652-Week High
23.28CNYUpdated Sep 21, 202652-Week Change
-41.82%vs all stocks
Beta
0.0830xvs all stocks
50-Day MA
12.78CNYUpdated Sep 21, 2026200-Day MA
14.94CNYUpdated Sep 21, 2026Avg 10-Day Volume
10.04MSharesUpdated Sep 21, 2026Avg 30-Day Volume
13.33MSharesUpdated Sep 21, 2026Diluted EPS (TTM)
0.2100CNYUpdated Sep 21, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 7.22: safe zoneNotable
Altman Z-Score: 7.22
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Market cap is $1.73B, above the global median of $1.18BNotable
Market cap (USD): 1,725,597,205.783Global Median: 1,180,223,658.953
Companies that share the same coordination system — how they create, deliver, or capture value.
Alembic Pharmaceuticals Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Jiangxi Fushine Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Shenzhen Edge Medical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Shenzhen Chipscreen Biosciences Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Hanall Biopharma Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Nanobiotix S.A.
Tier 1ProductionApproval-Gated PipelineRule
Inventisbio Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Jubilant Pharmova Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Green Thumb Industries Inc.
Tier 1ProductionApproval-Gated PipelineFlowRule
Yifan Pharmaceutical Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow